申请人:The Procter &Gamble Company
公开号:US20040142975A1
公开(公告)日:2004-07-22
Disclosed are compounds which are inhibitors of metalloproteases and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the compounds have a structure according to the following Formula (I):
1
where R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, G and Z have the meanings described in the specification. This invention also includes optical isomers, diastereomers and enantiomers of Formula I, and pharmaceutically-acceptable salts, biohydrolyzable amides, esters, and imides thereof. Also described are pharmaceutical compositions comprising these compounds, and methods of treating metalloprotease-related maladies using the compounds or the pharmaceutical compositions.
本发明揭示了一类金属蛋白酶抑制剂,可用于治疗由这些酶过度活性引起的疾病。具体而言,该类化合物的结构如下式(I)所示:其中,R1、R2、R3、R4、R5、R6、G和Z的含义在说明书中有所描述。本发明还包括式(I)的光学异构体、对映异构体和对映体,以及其药学上可接受的盐、生物可水解的酰胺、酯和亚胺。此外,还描述了包含这些化合物的药物组合物,并使用这些化合物或药物组合物治疗金属蛋白酶相关疾病的方法。